# RAB6B

## Overview
RAB6B is a gene that encodes a member of the Rab family of small GTPases, specifically the RAB6B protein, which plays a critical role in intracellular membrane trafficking. The RAB6B protein is involved in the regulation of vesicular transport processes, particularly within the secretory pathway, and is predominantly localized to the Golgi apparatus and post-Golgi vesicles. As a small GTPase, RAB6B functions by cycling between active GTP-bound and inactive GDP-bound states, facilitating interactions with various effector proteins to mediate transport activities. Notably, RAB6B is expressed in the brain, where it is implicated in neuronal functions such as axonal guidance and synaptic vesicle dynamics. The gene's expression and mutations have been associated with several diseases, including cancers and autoimmune disorders, highlighting its significance in both normal physiology and disease pathogenesis (GarciaSaez2006The; Wanschers2007Rab6; Peng2022RAB6B).

## Structure
The RAB6B protein is a member of the Rab family of small GTPases, which are involved in intracellular membrane trafficking. The primary structure of RAB6B consists of 208 amino acids, with a catalytic domain that includes GTP-binding motifs and a C-terminal hypervariable region (GarciaSaez2006The). The secondary structure features a classical Ras-like small GTPase fold, comprising a six-stranded mixed beta-sheet surrounded by five alpha-helices (GarciaSaez2006The). 

In terms of tertiary structure, the protein undergoes conformational changes between its inactive GDP-bound and active GTP-bound states, primarily in the switch I and switch II regions, which are crucial for effector interactions (GarciaSaez2006The). The active form of RAB6B, bound to GTPS, is more compact with exposed polar residues, while the inactive GDP-bound form has fewer intermolecular hydrogen bonds and displays higher flexibility in the switch regions (GarciaSaez2006The).

RAB6B is specifically expressed in the brain and has distinct biochemical properties compared to its isoform Rab6A, including lower GTP-binding activity and a different distribution over the Golgi and ER membranes (GarciaSaez2006The). The protein is involved in retrograde transport and interacts with various effectors, such as Rab6 GTPase-activating protein GAPCenA and Rabkinesin-6 (GarciaSaez2006The).

## Function
RAB6B is a member of the Rab6 family of small GTPases, which are involved in intracellular transport processes. In healthy human cells, RAB6B plays a crucial role in vesicular transport, particularly in the secretory pathway. It is localized to the Golgi apparatus and post-Golgi vesicles, where it is involved in both anterograde and retrograde transport of vesicles. This includes the movement of materials from the Golgi apparatus to other parts of the cell and the retrieval of specific proteins to the Golgi (Wanschers2007Rab6).

RAB6B interacts with the dynein light chain protein DYNLRB1, linking it to the dynein motor protein complex, which facilitates retrograde vesicle movement. Anterograde movement is regulated by kinesin family motor proteins (Wanschers2007Rab6). RAB6B is also involved in the transport of GPI-anchored proteins and may play a role in endocytosis, particularly in the internalization of these proteins (Wanschers2007Rab6).

In the brain, RAB6B is expressed in neurons and is implicated in neuronal function, potentially influencing axonal guidance and synaptic vesicle dynamics (Wanschers2007Rab6). Its disruption in mice leads to growth retardation and neurological defects, underscoring its importance in normal physiological processes (Wanschers2007Rab6).

## Clinical Significance
Alterations in the expression and genetic mutations of the RAB6B gene have been implicated in various diseases, particularly cancers. In hepatocellular carcinoma (HCC), RAB6B expression is significantly elevated compared to normal liver tissues. This upregulation is associated with advanced tumor stages, higher histological grades, and poor overall survival, making RAB6B an independent prognostic marker for HCC. The gene's expression is also linked to an immunosuppressive tumor microenvironment, potentially leading to CD8+ T cell exhaustion and recruitment of immunosuppressive cells (Peng2022RAB6B).

In pancreatic ductal adenocarcinoma (PDAC), RAB6B is notably downregulated, and this low expression correlates with poorer survival outcomes. Despite its downregulation, RAB6B shows gene amplification and is subject to deep deletions and missense mutations, suggesting complex genomic alterations that may impact prognosis (Anand2020Comprehensive).

Additionally, RAB6B has been identified as a target of autoantibodies in primary autoimmune cerebellar ataxia associated with Sjogren's syndrome. The presence of these autoantibodies suggests a potential role for RAB6B in the pathogenesis of this neurological disorder (Guo2021Autoantibody).

## Interactions
RAB6B, a member of the RAS oncogene family, is involved in various protein interactions that are crucial for its role in intracellular transport. It interacts directly with DYNLRB1, a component of the dynein motor protein complex, which suggests a role in microtubular transport. This interaction is nucleotide-dependent, varying with the GTP or GDP-bound state of the Rab6 isoforms, and is unique to DYNLRB1 as DYNLRB2 does not exhibit the same binding capability (Wanschers2007A).

RAB6B also interacts with Bicaudal-D1, a coiled-coil protein associated with the dynein-dynactin complex, which is involved in retrograde transport in neuronal cells. This interaction has been confirmed through co-immunoprecipitation and pull-down experiments, and it is suggested that RAB6B may stabilize the binding of other proteins to the dynein complex, forming a multiprotein assembly with specific functional roles in retrograde transport (Wanschers2007A; Wanschers2007Rab6).

Additionally, RAB6B is involved in interactions with other Rab proteins, such as Rab6IP1 and Giantin, which interact with Rab11 and Rab1, respectively. These interactions highlight RAB6B's role in complex regulatory networks within the cell (Wanschers2007A; Wanschers2007Rab6).


## References


[1. (GarciaSaez2006The) Isabel Garcia-Saez, Sergey Tcherniuk, and Frank Kozielski. The structure of human neuronal rab6b in the active and inactive form. Acta Crystallographica Section D Biological Crystallography, 62(7):725–733, June 2006. URL: http://dx.doi.org/10.1107/s0907444906015319, doi:10.1107/s0907444906015319. This article has 17 citations.](https://doi.org/10.1107/s0907444906015319)

[2. (Wanschers2007A) Bas F.J. Wanschers, Rinske van de Vorstenbosch, Max A. Schlager, Daniël Splinter, Anna Akhmanova, Casper C. Hoogenraad, Bé Wieringa, and Jack A.M. Fransen. A role for the rab6b bicaudal–d1 interaction in retrograde transport in neuronal cells. Experimental Cell Research, 313(16):3408–3420, October 2007. URL: http://dx.doi.org/10.1016/j.yexcr.2007.05.032, doi:10.1016/j.yexcr.2007.05.032. This article has 58 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2007.05.032)

[3. (Guo2021Autoantibody) Liyuan Guo, Haitao Ren, Siyuan Fan, Hongzhi Guan, and Jing Wang. Autoantibody against the rab6a/rab6b in primary autoimmune cerebellar ataxia associated with sjogren’s syndrome: a case report. Journal of Neuroimmunology, 359:577667, October 2021. URL: http://dx.doi.org/10.1016/j.jneuroim.2021.577667, doi:10.1016/j.jneuroim.2021.577667. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jneuroim.2021.577667)

[4. (Anand2020Comprehensive) Shashi Anand, Mohammad Aslam Khan, Moh’d Khushman, Santanu Dasgupta, Seema Singh, and Ajay Pratap Singh. Comprehensive analysis of expression, clinicopathological association and potential prognostic significance of rabs in pancreatic cancer. International Journal of Molecular Sciences, 21(15):5580, August 2020. URL: http://dx.doi.org/10.3390/ijms21155580, doi:10.3390/ijms21155580. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21155580)

[5. (Wanschers2007Rab6) Bas Wanschers, Rinske van de Vorstenbosch, Mietske Wijers, Bé Wieringa, Stephen M. King, and Jack Fransen. Rab6 family proteins interact with the dynein light chain protein dynlrb1. Cell Motility, 65(3):183–196, November 2007. URL: http://dx.doi.org/10.1002/cm.20254, doi:10.1002/cm.20254. This article has 69 citations.](https://doi.org/10.1002/cm.20254)

[6. (Peng2022RAB6B) Hao Peng, Erwei Zhu, Jitao Wang, Xuanlong Du, Chonggao Wang, Meng Yang, and Yewei Zhang. Rab6b is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma. Frontiers in Pharmacology, September 2022. URL: http://dx.doi.org/10.3389/fphar.2022.989655, doi:10.3389/fphar.2022.989655. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2022.989655)